According to the new market research report "Flow Cytometry Market by Product (Analyzer, Sorter, Reagents, Consumables, Software), Technology, Application (Research, Clinical - Cancer Diagnostics, Hematology), End User (Academia, Research Labs, Pharma, Biotech, Hospitals) - Global Forecast to 2026", published by MarketsandMarkets™, the market is projected to reach USD 6.3 billion by 2026 from USD 4.3 billion in 2021, at a CAGR of 8.1%.
Browse
in-depth TOC on "Flow
Cytometry Market"
263 – Tables
40 – Figures
282 – Pages
Download
PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584
The Growth in the flow cytometry market is largely
driven by the rising global incidence and prevalence of HIV/AIDS and cancer,
growing adoption of flow cytometry techniques in research and academia, growing
public-private initiatives in the fields of immunology and immuno-oncology
research, technological advancements, increasing incorporation of AI platforms
in flow cytometry workflows, and increasing advancements in flow cytometry
software. However, the high cost of flow cytometry products is a major factor
hampering the growth of the market.
The bead-based flow cytometry segment is expected to
grow at the highest CAGR during the forecast period
On the basis of technology, the global flow
cytometry market is segmented into cell-based and bead-based flow cytometry.
The bead-based flow cytometry segment is estimated to witness the highest
growth during the forecast period. This technology offers various procedural
advantages over other cell-based assays, such as the capacity to detect
multiple analytes (also known as multiplexing), high reproducibility,
stability, and speed.
Cancer
diagnostic segment hold the largest share of the flow cytometry for clinical
application market in 2020
In this report, the flow cytometry market for
clinical applications is segmented into organ & tissue transplantations,
cancer diagnostics, immunodeficiency diseases, hematology, and other clinical
applications. Flow cytometry can be applied to cancer studies at every stage by
measuring the amount of DNA in cancer cells, analyzing tumor cell
proliferation, and immunophenotyping hematological malignancies. In addition,
flow cytometry tools are used to determine the malignancy of a tumor by
analyzing and enumerating a number of chromosomes and can thus be used to
detect cancerous cells.
Request
Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584
The Asia Pacific region is the
fastest-growing region of the flow cytometry market in 2020.
In 2020, the Asia Pacific region accounted
for the fasted growing region of the market. The APAC market is expected to
offer significant growth opportunities to key market players during the
forecast period. Countries in this region are witnessing sustained growth in
their GDPs and the disposable incomes of their middle-class population. This is
expected to replicate into growth in healthcare spending, research
infrastructure modernization, and increased penetration of advanced
technologies (including advanced flow cytometry technologies) for research and
clinical applications.
The major players operating in the flow cytometry
market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo
Fisher Scientific, Inc. (US), Luminex Corporation (US), Agilent Technologies,
Inc. (US), Sony Group Corporation (Japan), Bio-Rad Laboratories, Inc.
(US), Miltenyi Biotec GmbH (Germany),
Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMérieux S.A. (France),
Cytonome/ ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences, Inc.
(US), Union Biometrica, Inc. (US), Apogee Flow Systems Ltd. (UK), Stratedigm,
Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co.,
Ltd. (Japan),
NEXCELOM BIOSCIENCE LLC (US), BennuBio Inc. (US), ORFLO Technologies (US), Bay
Biosciences Co., Ltd. (Japan),
BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands).
Browse
Related Reports:
Cell Analysis Market by
Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)],
Process (Cell Viability, Cell Proliferation, Signal Transduction), End User
(Pharma, Research, Biotechnology Companies) - Global Forecast to 2024
No comments:
Post a Comment